Pathology Revenue and Competitors
Estimated Revenue & Valuation
- Pathology's estimated annual revenue is currently $59.2M per year.
- Pathology's estimated revenue per employee is $363,258
- Pathology's total funding is $32.3M.
Employee Data
- Pathology has 163 Employees.
- Pathology grew their employee count by 1% last year.
Pathology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $727M | 3780 | N/A | N/A | $2.2B |
#2 | $223.8M | 663 | -8% | N/A | N/A |
What Is Pathology?
Pathology Inc. is a 30 man pathology group headquartered in suburban Los Angeles, California offering multi-specialty pathology services for primary care and specialty physicians. The group also practices at 12 area hospitals. This arrangement allows for direct pathologist control over the technical operations resulting in quality control and rapid turnaround time for all office based specimens.
keywords:N/A
$32.3M
Total Funding
163
Number of Employees
$59.2M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pathology News
It can also point out hotspots that are particularly crowded with estrogen receptors. With that analysis, pathologists can make a definitive...
Tran is the senior director of clinical pathology at UC Davis Health and a key figure in COVID-19 testing. Over the past two years, he emerged...
Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson's...
Co-founder and CEO Brad Brooks outlined a few examples of how the API is being used. Pathology Inc., a women’s health lab, is using it to send lab alerts to its physician customers. A partnership with Ontario-based PointClickCare helped expand its secure messaging service to the senior care mark ...
Other Companies in Torrance
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26M | 163 | 60% | N/A |
#2 | $55.9M | 165 | 34% | N/A |
#3 | $44.6M | 167 | -7% | N/A |
#4 | $45.5M | 169 | 5% | N/A |
#5 | $47.3M | 172 | 47% | N/A |